The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.

TitleA tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.
Publication TypeJournal Article
Year of Publication2009
AuthorsKriki, P., Thodis E., Deftereos S., Panagoutsos S., Theodoridis M., Kantartzi K., Mourvati E., Prassopoulos P., Passadakis P., & Vargemezis V.
JournalClin Nephrol
Volume71
Issue6
Pagination714-8
Date Published2009 Jun
ISSN0301-0430
KeywordsDiabetic Nephropathies, Diagnosis, Differential, Drug Therapy, Combination, Ethambutol, Humans, Isoniazid, Liver, Liver Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged, Mycobacterium tuberculosis, Pyrazinamide, Renal Dialysis, Rifampin, Tomography, X-Ray Computed, Tuberculosis, Hepatic
Abstract

Though pulmonary tuberculosis (TBC) remains the commonest clinical presentation, extrapulmonary TBC is an increasingly important clinical problem. Among the extrapulmonary sites, primary liver tuberculosis seems to be an extremely rare location. Fewer than 100 cases of TBC hepatic abscesses have been reported whereas most of them have been originated from other sites, usually the lung and the gastrointestinal track. Therefore, in the absence of any particular symptom this infrequent location may lead to a delayed or missing diagnosis. The present study reports the difficulties in early diagnosis of an extrapulmonary TBC case, as it happened to a 53-year-old man with diabetic nephropathy who started on regular hemodialysis for 5 months. In such "atypical presentations" the clinicians should bear in their mind the possibility of the TBC occurrence, which usually responds well to the conventional antituberculous therapy.

DOI10.5414/cnp71714
Alternate JournalClin Nephrol
PubMed ID19473642

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.